OR
CANO

Olympiad Research’s Cano Health, Inc. CANO Stock Holding History

Olympiad Research’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$244K Buy
+282
New +$177K 0.13% 176

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Olympiad Research's CANO Position: Q3 2022 in Review

Olympiad Research opened a new position in Cano Health, Inc. (CANO) in Q3 2022: 282 shares worth $244K. The stake represents 0.13% of the portfolio and ranks #176 among its holdings.

173 funds tracked by Wall St. Rank hold CANO as of Q3 2022.

  • Olympiad Research held 282 shares of Cano Health, Inc. worth $244K as of Q3 2022.
  • Cano Health, Inc. was a new Olympiad Research position in Q3 2022.
  • Cano Health, Inc. made up 0.13% of Olympiad Research's portfolio in Q3 2022, its #176 holding.
  • 173 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.